Central Trust Company’s NEVRO CORP. NVRO Stock Holding History

Central Trust Company’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-75	Closed	-$12K	–	1308
2021 Q2	$12K	Buy	+75	New	+$11.7K	﹤0.01%	995

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Central Trust Company's NVRO Position: Q3 2021 in Review

Central Trust Company sold out of NEVRO CORP. (NVRO) in Q3 2021, closing a stake of 75 shares — an estimated $12K sold.

Central Trust Company first reported a position in NVRO in Q2 2021 and held it in 1 quarter. The position peaked at $12K in Q2 2021. 194 funds tracked by Wall St. Rank hold NVRO as of Q3 2021.

Central Trust Company reported no remaining NEVRO CORP. position as of Q3 2021 after selling out during the quarter.
Central Trust Company sold 75 NEVRO CORP. shares in Q3 2021, an estimated $12K.
Central Trust Company first reported a position in NEVRO CORP. in Q2 2021 and held it in 1 quarter.
Central Trust Company's NEVRO CORP. position peaked at $12K in Q2 2021.
194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2021.

Based on Central Trust Company's 13F filing for Q3 2021, filed 19 Oct 2021.